ACvA (@ozcva) 's Twitter Profile
ACvA

@ozcva

Bringing the cardiovascular and stroke research sector together to collaboratively develop solutions to the most pressing areas of need

ID: 4142040914

linkhttp://www.ozheart.org calendar_today06-11-2015 03:55:44

5,5K Tweet

3,3K Followers

3,3K Following

NSW CVRN (@nswcvrn) 's Twitter Profile Photo

NSW CVRN The HEART Pitch 2024 - DEADLINE EXTENDED AND SIMPLER ENTRY PROCESS! Submit a short and 60-second video or a 300-word abstract about your research for a chance to win a $1,000 prize! Entry closes on 9 September. View details and apply here: shorturl.at/Zr3Rd

<a href="/NSWCVRN/">NSW CVRN</a> The HEART Pitch 2024 - DEADLINE EXTENDED AND SIMPLER ENTRY PROCESS!
Submit a short and 60-second video or a 300-word abstract about your research for a chance to win a $1,000 prize! Entry closes on 9 September. View details and apply here: shorturl.at/Zr3Rd
Heart Foundation (@heartfoundation) 's Twitter Profile Photo

COMING SOON: The Global Cardiovascular Research Funders Forum presents the International Research Challenge on Women’s Cardiovascular Health at the European Society of Cardiology Congress. How can researchers apply for this US$10 million grant? Stay tuned on 25 September 📢 #ESC #GCRFF #CVDresearch

COMING SOON: The Global Cardiovascular Research Funders Forum presents the International Research Challenge on Women’s Cardiovascular Health at the <a href="/escardio/">European Society of Cardiology</a> Congress. How can researchers apply for this US$10 million grant? Stay tuned on 25 September 📢 #ESC #GCRFF #CVDresearch
Emma Solly (@emma_solly) 's Twitter Profile Photo

So grateful to be at #ESCCongress2024 I'll be presenting my poster on miR-181c and diabetes-impaired angiogenesis at station 9 today at 4 pm. Come and say hi if you are here!

So grateful to be at #ESCCongress2024 I'll be presenting my poster on miR-181c and diabetes-impaired angiogenesis at station 9 today at 4 pm. Come and say hi if you are here!
Caleb Ferguson (@calebferg) 's Twitter Profile Photo

Current frailty knowledge, awareness, and practices among physicians following the 2022 European consensus document on Frailty in Cardiology #ESCCongress2024 academic.oup.com/ehjopen/articl…

Hypertension Australia (@hypertensionaus) 's Twitter Profile Photo

Member Spotlight: Professor Mark Nelson 🩺 23-year @HypertensionAU member revolutionising cardiovascular research. His message: "Treat high BP in the elderly. They have the most to gain and aren't at the adverse risk you think!" Learn more: tinyurl.com/nh93avb4

Member Spotlight: Professor Mark Nelson 🩺
23-year @HypertensionAU member revolutionising cardiovascular research. His message:
"Treat high BP in the elderly. They have the most to gain and aren't at the adverse risk you think!"
Learn more: tinyurl.com/nh93avb4
MTPConnect (@mtpconnect_aus) 's Twitter Profile Photo

📢NEWS! MTPConnect will inject much-needed funding & support for🇦🇺SMEs to commercialise innovative medical products to better treat cardiovascular disease & diabetes through new $28.5M investment through Targeted Translation Research Accelerator (TTRA).1/5 bit.ly/3MrioQ7

📢NEWS! MTPConnect will inject much-needed funding &amp; support for🇦🇺SMEs to commercialise innovative medical products to better treat cardiovascular disease &amp; diabetes through new $28.5M investment through Targeted Translation Research Accelerator (TTRA).1/5 bit.ly/3MrioQ7
Baker Institute (@bakerresearchau) 's Twitter Profile Photo

Great to see spotlight on Nirtek in TV story below. This startup was developed off the back of pioneering research by KarlheinzPeter. Nirtek was developed to prevent #heartattacks by detecting unstable coronary plaques using patented technology called near infrared autofluorescence

Caleb Ferguson (@calebferg) 's Twitter Profile Photo

Hope you can join us for an exciting 1 day Implementation Science Symposium in Wollongong in October - a great line up of speakers. More info uow.edu.au/events/2024/im… #ImplementationScience #KnowledgeTranslation #Wollongong @uow

ACTA: Australian Clinical Trials Alliance (@acta_org) 's Twitter Profile Photo

The abstract submission deadline for the ACTA 2024 Clinical Trials and Registries Symposium has been extended to Monday 16 September. Visit the conference website to view the themes and to submit your abstract bit.ly/2024_ACTA #ACTA2024 #abstracts #clinicaltrials

The abstract submission deadline for the ACTA 2024 Clinical Trials and Registries Symposium has been extended to Monday 16 September. 

Visit the conference website to view the themes and to submit your abstract bit.ly/2024_ACTA

#ACTA2024 #abstracts #clinicaltrials
ACvA (@ozcva) 's Twitter Profile Photo

Opening remarks from Dr Cae Tolman to kick off our CAD workshop at UOW today Identifying drivers of disparities in regional settings & approaches for measurable improvments. #ACvDCADtheGong Amgen 🧪🔬🧬 [email protected] keiko @SAHMRI Judy Mullan @Novarti

Opening remarks from Dr Cae Tolman to kick off our CAD workshop at <a href="/UOW/">UOW</a> today Identifying drivers of disparities in regional settings &amp; approaches for measurable improvments.
#ACvDCADtheGong
<a href="/Amgen/">Amgen 🧪🔬🧬</a> <a href="/KerryDozheart/">kcg1056@gmail.com</a> <a href="/gemtree/">keiko</a> @SAHMRI <a href="/MullanJudy/">Judy Mullan</a> @Novarti
ACvA (@ozcva) 's Twitter Profile Photo

Peter Psaltis chairing Session 1 at our workshop discussing the disparities in Coronary Artery Disease across regional Australia at UOW today. How can we drive real change? #ACvACADtheGong #CAD @SAHMRI [email protected] Prof Jason Kovacic Prof Gemma Figtree AM Amgen 🧪🔬🧬 Novartis

Peter Psaltis chairing Session 1 at our workshop discussing the disparities in Coronary Artery Disease across regional Australia at <a href="/UOW/">UOW</a> today. How can we drive real change? #ACvACADtheGong #CAD 
@SAHMRI <a href="/KerryDozheart/">kcg1056@gmail.com</a> <a href="/kovacic_jason/">Prof Jason Kovacic</a> <a href="/gemtreee/">Prof Gemma Figtree AM</a> <a href="/Amgen/">Amgen 🧪🔬🧬</a> <a href="/Novartis/">Novartis</a>
ACvA (@ozcva) 's Twitter Profile Photo

Heidi Dietz from AIHW shares key insights and future directions for monitoring chronic conditions in relation to CAD at our workshop at UOW today identifying Key Drivers of Disparities in a Regional Setting. #ACvACADtheGong Prof Gemma Figtree AM Amgen 🧪🔬🧬 Novartis SAHMRI [email protected]

Heidi Dietz from AIHW shares key insights and future directions for monitoring chronic conditions in relation to CAD at our workshop at <a href="/UOW/">UOW</a> today identifying Key Drivers of Disparities in a Regional Setting.
#ACvACADtheGong <a href="/gemtreee/">Prof Gemma Figtree AM</a> <a href="/Amgen/">Amgen 🧪🔬🧬</a> <a href="/Novartis/">Novartis</a> <a href="/sahmriAU/">SAHMRI</a> <a href="/KerryDozheart/">kcg1056@gmail.com</a>
ACvA (@ozcva) 's Twitter Profile Photo

Dr Suado Abdilahi Mohamed of Novartis closed today’s ACvA Coronary Artery Disease workshop at UOW bringing together experts from the Illawarra & beyond to discuss CAD in the Illawarra region. #ACvACADtheGong

Dr Suado Abdilahi Mohamed of <a href="/Novartis/">Novartis</a> closed today’s ACvA Coronary Artery Disease workshop at <a href="/UOW/">UOW</a> bringing together experts from the Illawarra &amp; beyond to discuss CAD in the Illawarra region. #ACvACADtheGong
ACvA (@ozcva) 's Twitter Profile Photo

Thank you to all of our speakers & participants for their valuable insights on Coronary Artery Disease in the Illawarra today, also to UOW for hosting us and Amgen 🧪🔬🧬 & Novartis for supporting the event. #ACvACADtheGong

Thank you to all of our speakers &amp; participants for their valuable insights on Coronary Artery Disease in the Illawarra today, also to <a href="/UOW/">UOW</a> for hosting us and <a href="/Amgen/">Amgen 🧪🔬🧬</a> &amp; <a href="/Novartis/">Novartis</a> for supporting the event.  #ACvACADtheGong